The Chinese e-commerce giant will gain greater access to entertainment content through the $800 million investment.
Offer from Numericable/Altice seen less likely to trigger antitrust concern than Bouygues bid, which would cut number of wireless providers in Europe to three from four.
Dublin-based generic drug company Actavis on Tuesday unveiled a $25 billion agreed cash-and-stock offer for New York rival Forest Laboratories to expand in branded drugs as a pharmaceuticals consolidation continues.
Irish buyer offers a 26% premium to secure Cadence's Ofirmev injectable pain killer, which recently won approval in Canada.
Acquisitive cable company Liberty Global on Monday announced an agreement to buy the outstanding shares in Dutch cable company Ziggo in a deal with an enterprise value of 10 billion ($13.7 billion).
AT&T T says it has no plans to make an offer for U.K. rival Vodafone Group but didn't entirely close the door on an approach.
San Francisco drug distributor McKesson late Thursday, Jan. 23, revived a failed 6.4 billion ($8.8 billion) offer for Germany's Celesio, reeling in 76% from Franz Haniel & Cie Gmbh, a Duisburg, Germany-based family-run conglomerate.
Chinese personal computer maker Lenovo on Thursday, Jan. 23, agreed to buy the low-power server business of IBM IBM for $2.3 billion, two days after confirming it had entered talks.
Telecom Italia said it would create guidelines for handling any offers for its Brazilian unit.
McKesson is mulling other ways of linking up with the German drug distributor, which analysts predicted may soon attract a new suitor.